JGGDR
ALXN

JGP Global Gestao de Recursos’s Alexion Pharmaceuticals ALXN Stock Holding History

JGP Global Gestao de Recursos’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,921
Closed -$904K – 92
2021
Q2 		$904K Buy
4,921
+5
+0.1% +$858 0.3% 26
2021
Q1 		$752K Sell
4,916
-1,493
-23% -$231K 0.47% 20
2020
Q4 		$1M Sell
6,409
-4
-0.1% -$514 3.76% 8
2020
Q3 		$734K Sell
6,413
-73
-1% -$7.88K 0.4% 24
2020
Q2 		$728K Hold
6,486
– – 0.43% 19
2020
Q1 		$582K Sell
6,486
-1,063
-14% -$104K 0.25% 30
2019
Q4 		$816K Buy
7,549
+84
+1% +$8.98K 0.29% 29
2019
Q3 		$731K Buy
7,465
+941
+14% +$106K 0.4% 25
2019
Q2 		$855K Sell
6,524
-313
-5% -$40.3K 0.34% 18
2019
Q1 		$924K Buy
6,837
+388
+6% +$48.2K 0.34% 18
2018
Q4 		$628K Buy
+6,449
New +$762K 0.76% 14
2017
Q3 		– Sell
-10,743
Closed -$1.31M – 37
2017
Q2 		$1.31M Buy
10,743
+1,498
+16% +$174K 1.73% 8
2017
Q1 		$1.12M Sell
9,245
-4,736
-34% -$611K 0.93% 9
2016
Q4 		$1.71M Buy
13,981
+1,002
+8% +$123K 0.88% 12
2016
Q3 		$1.59M Sell
12,979
-1,291
-9% -$166K 0.15% 10
2016
Q2 		$1.67M Buy
14,270
+1,455
+11% +$206K 0.32% 13
2016
Q1 		$1.78M Buy
12,815
+8,813
+220% +$1.29M 0.75% 10
2015
Q4 		$763K Buy
+4,002
New +$699K 0.65% 25

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

JGP Global Gestao de Recursos's ALXN Position: Q3 2021 in Review

JGP Global Gestao de Recursos sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,921 shares — an estimated $904K sold.

JGP Global Gestao de Recursos first reported a position in ALXN in Q4 2015 and held it in 18 quarters. The position peaked at $1.78M in Q1 2016. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • JGP Global Gestao de Recursos reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 4,921 Alexion Pharmaceuticals shares in Q3 2021, an estimated $904K.
  • JGP Global Gestao de Recursos first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 18 quarters.
  • JGP Global Gestao de Recursos's Alexion Pharmaceuticals position peaked at $1.78M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2021, filed 4 Nov 2021.